Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M A Wallace

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of STD & AIDS|August 27, 2002
Haematospermia: in the context of a genitourinary medicine settingN Narouz, D M A Wallace
Oncology Reports|December 7, 2002
Management of renal angiomyolipoma in patients with tuberous sclerosis complexJ L Simmons, S A Hussain, P Riley, et al.
BJU International|May 16, 2002
Delay and survival in bladder cancerD M A Wallace, R T Bryan, J A Dunn, et al.
Springerplus|February 6, 2016
Urologist led one-stop testicular clinic: the UK 'gold standard'David Muthuveloe, Nkwam Nkwam, Paul Hutton, et al.
Expert Opinion on Pharmacotherapy|December 11, 2002
Luteinising hormone releasing hormone analogues in the treatment of prostate cancerLyndon M Gommersall, Dickon Hayne, Iqbal S Shergill, et al.
The Journal of Urology|October 9, 2003
The role of beta-catenin signaling in the malignant potential of cystitis glandularisR T Bryan, J H Nicholls, R F Harrison, et al.
BJU International|July 23, 2002
Does smoking status influence the prognosis of bladder cancer? A systematic reviewP Aveyard, P Adab, K K Cheng, et al.
Oncology Reports|September 18, 2004
CD40 expression in prostate cancer: a potential diagnostic and therapeutic moleculeD H Palmer, S A Hussain, R Ganesan, et al.
The Journal of Pathology|April 9, 2008
Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studiesR T Bryan, P A Atherfold, Y Yeo, et al.
British Journal of Cancer|May 20, 2004
Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancerS A Hussain, D D Stocken, D R Peake, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of STD & AIDS|August 27, 2002
Haematospermia: in the context of a genitourinary medicine settingN Narouz, D M A Wallace
Oncology Reports|December 7, 2002
Management of renal angiomyolipoma in patients with tuberous sclerosis complexJ L Simmons, S A Hussain, P Riley, et al.
BJU International|May 16, 2002
Delay and survival in bladder cancerD M A Wallace, R T Bryan, J A Dunn, et al.
Springerplus|February 6, 2016
Urologist led one-stop testicular clinic: the UK 'gold standard'David Muthuveloe, Nkwam Nkwam, Paul Hutton, et al.
Expert Opinion on Pharmacotherapy|December 11, 2002
Luteinising hormone releasing hormone analogues in the treatment of prostate cancerLyndon M Gommersall, Dickon Hayne, Iqbal S Shergill, et al.
The Journal of Urology|October 9, 2003
The role of beta-catenin signaling in the malignant potential of cystitis glandularisR T Bryan, J H Nicholls, R F Harrison, et al.
BJU International|July 23, 2002
Does smoking status influence the prognosis of bladder cancer? A systematic reviewP Aveyard, P Adab, K K Cheng, et al.
Oncology Reports|September 18, 2004
CD40 expression in prostate cancer: a potential diagnostic and therapeutic moleculeD H Palmer, S A Hussain, R Ganesan, et al.
The Journal of Pathology|April 9, 2008
Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studiesR T Bryan, P A Atherfold, Y Yeo, et al.
British Journal of Cancer|May 20, 2004
Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancerS A Hussain, D D Stocken, D R Peake, et al.
Pageof 2